Machine learning assisted risk stratification of newly diagnosed multiple myeloma with respect to the VRd treatment

被引：0

作者：

Koo, Jamin ^{[1
]}

Choi, Gyucheol ^{[2
]}

Park, Sung-Soo ^{[3
]}

Byun, Ja Min ^{[4
]}

Lim, Sungwon ^{[1
]}

Lee, Jong Cheol ^{[5
]}

机构：

[1] ImpriMed Inc, Mountain View, CA USA

[2] ImpriMedKorea Inc, Seoul, South Korea

[3] Catholic Univ Korea, Seoul St Marys Hematol Hosp, Dept Hematol, Coll Med, Seoul, South Korea

[4] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea

[5] Ulsan Univ, Ulsan, South Korea

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-118

引用

页码：S100 / S101

页数：2

共 50 条

[21] Phase 2 Suzhou MM02 Study: Chidamide with VRD Versus VRD in Newly Diagnosed High Risk Transplant Eligible Multiple Myeloma Patients [J].

Yao, Weiqin ;

Yan, Lingzhi ;

Shang, Jingjing ;

Jin, Song ;

Shi, Xiaolan ;

Yan, Shuang ;

Wu, Depei ;

Fu, Chengcheng .

BLOOD, 2021, 138

[22] Risk Factors Predicting Early Relapse for Newly Diagnosed Multiple Myeloma Patients Treated with Front-Line VRD Regimen [J].

Cheng, Lili ;

Wang, Wei ;

Li, Hui ;

Cai, Hao ;

Zhang, Fujing ;

Liu, Shuangjiao ;

Zhuang, Junling .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S154-S154

[23] Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting [J].

Bonello, Francesca ;

Cani, Lorenzo ;

D'Agostino, Mattia .

FRONTIERS IN ONCOLOGY, 2022, 12

[24] Treatment paradigms for the newly diagnosed patient with multiple myeloma [J].

Greipp, P .

SEMINARS IN HEMATOLOGY, 2005, 42 (04) :S16-S21

[25] Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma [J].

Palumbo, Antonio ;

Hajek, Roman ;

Delforge, Michel ;

Kropff, Martin ;

Petrucci, Maria Teresa ;

Catalano, John ;

Gisslinger, Heinz ;

Wiktor-Jedrzejczak, Wieslaw ;

Zodelava, Mamia ;

Weisel, Katja ;

Cascavilla, Nicola ;

Iosava, Genadi ;

Cavo, Michele ;

Kloczko, Janusz ;

Blade, Joan ;

Beksac, Meral ;

Spicka, Ivan ;

Plesner, Torben ;

Radke, Joergen ;

Langer, Christian ;

Ben Yehuda, Dina ;

Corso, Alessandro ;

Herbein, Lindsay ;

Yu, Zhinuan ;

Mei, Jay ;

Jacques, Christian ;

Dimopoulos, Meletios A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1759-1769

[26] Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma [J].

Elnair, Radowan A. ;

Holstein, Sarah A. .

DRUGS, 2021, 81 (07) :825-840

[27] TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA: GOALS AND OPTIONS [J].

Tacchetti, P. ;

Zamagni, E. ;

Pantani, L. ;

Cavo, M. .

HAEMATOLOGICA, 2017, 102 :212-215

[28] Evolving Paradigms in the Treatment of Newly Diagnosed Multiple Myeloma [J].

Larocca, Alessandra ;

Palumbo, Antonio .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10) :1186-1196

[29] The role of carfilzomib in treatment of newly diagnosed multiple myeloma [J].

Strifler, Susanne ;

Knop, Stefan .

FUTURE ONCOLOGY, 2018, 14 (30) :3123-3134

[30] Treatment patterns and outcomes in newly diagnosed multiple myeloma [J].

Shah, Jash Yogesh ;

Nair, Aditya Ranjithkumar ;

Mishra, Dhyey Rajkumar ;

Bagal, Bhausaheb ;

Jain, Hasmukh ;

Nayak, Lingaraj ;

Tembhare, Prashant ;

Saha, Saswata ;

Gokarn, Anant ;

Punatar, Sachin ;

Shetty, Dhanlaxmi ;

Mirgh, Sumeet ;

Shetty, Alok ;

Jindal, Nishant ;

Patil, Vasundhara ;

Sengar, Manju ;

Khattry, Navin .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S125-S125

← 1 2 3 4 5 →